ISPOR Europe 2026
Workshop Expanded Value Measures track
Early Value Assessment When There Are Multiple External Comparators: Introducing Value-Based Decision Boundary Analysis (VB-DBA)
Mon, Nov 9, 2026 · 10:30–11:30 AM CET Hall F2, Level 0, Austria Center Vienna
About this session
PURPOSE: Health technology developers (HTDs) currently use early cost-effectiveness models to determine economically justifiable prices (EJPs) based on target product profiles (TPPs). These are then used to evaluate future commercial decisions, such as whether to move forward with development or how to optimize launch. Whilst this analysis provides important insights, a major limitation is only being able to evaluate a single TPP at a time.
Speakers
-
Sanofi
Speaker
